Page last updated: 2024-11-02

pargyline and Paralysis

pargyline has been researched along with Paralysis in 2 studies

Pargyline: A monoamine oxidase inhibitor with antihypertensive properties.

Paralysis: A general term most often used to describe severe or complete loss of muscle strength due to motor system disease from the level of the cerebral cortex to the muscle fiber. This term may also occasionally refer to a loss of sensory function. (From Adams et al., Principles of Neurology, 6th ed, p45)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Zhou, SY1
Goshgarian, HG1
Simpson, LL1
Tapp, JT1

Other Studies

2 other studies available for pargyline and Paralysis

ArticleYear
Effects of serotonin on crossed phrenic nerve activity in cervical spinal cord hemisected rats.
    Experimental neurology, 1999, Volume: 160, Issue:2

    Topics: 5-Hydroxytryptophan; Animals; Asphyxia; Cervical Vertebrae; Female; Functional Laterality; Methyserg

1999
Partial antagonism of experimental botulinal intoxication.
    International journal of neuropharmacology, 1967, Volume: 6, Issue:6

    Topics: Animals; Antitoxins; Calcium; Clostridium botulinum; Diaphragm; Drug Antagonism; Female; In Vitro Te

1967